Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis
- 30 December 2003
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 126 (6) , 1935-1942
- https://doi.org/10.1016/j.jtcvs.2003.07.031
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and ImplicationsJournal of Clinical Oncology, 2000
- Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple StationsChest, 2000
- Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trialLung Cancer, 1999
- Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancerThe Annals of Thoracic Surgery, 1997
- Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease)European Journal of Cardio-Thoracic Surgery, 1996
- Results of surgical resection in patients with N2 non-small cell lung cancerThe Annals of Thoracic Surgery, 1994
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- Prognosis of unsuspected but completely resectable N2 non-small cell lung cancerThe Annals of Thoracic Surgery, 1993
- Aggressive surgical intervention in N2 non-small cell cancer of the lungThe Annals of Thoracic Surgery, 1991
- Surgical treatment of patients with nonsmall‐cell lung cancer and mediastinal lymph node involvementJournal of Surgical Oncology, 1990